Veterinary/Warning Letter·FDA Warning Letters

Warning Letter — DeJong Family Dairy, LLC

MediumPublished Aug 18, 2026· AI-analyzed Aug 19, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The FDA issued a Warning Letter to DeJong Family Dairy, LLC on July 30, 2026, following an inspection by the Center for Veterinary Medicine.

Who it affects

This affects DeJong Family Dairy, LLC, as well as regulatory and quality assurance personnel involved in dairy operations and veterinary drug administration.

Why it matters

A Warning Letter from the Center for Veterinary Medicine typically indicates significant deviations from food safety or drug administration standards. For dairy operations, this likely involves concerns regarding drug residues or improper animal treatment records, which could lead to the adulteration of food products entering the human supply chain.

Practical takeaway

Review and strengthen protocols for the administration of veterinary drugs and ensure comprehensive documentation of withdrawal periods to prevent residues in food products. Quality units should audit drug storage and administration records to confirm alignment with CVM regulations.

FDA source material

FDA Warning Letter issued to: DeJong Family Dairy, LLC. 07/30/2026 — Center for Veterinary Medicine. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dejong-family-dairy-llc-729293-07302026

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.